Quality and Testing

Independent third-party verification on every research peptide batch.

GENEVIUM research peptide vial held by a laboratory researcher in protective gloves and safety glasses inside a quality testing facility

Tested Before It Ships

Every GENEVIUM research peptide is independently tested by third-party analytical laboratories before release. Reverse-phase HPLC verifies purity to a minimum 99% threshold. Mass spectrometry confirms identity by molecular weight. Nothing ships until both standards are met and documented.

Quality begins upstream of testing. GENEVIUM works with a short list of vetted manufacturing partners and maintains documented chain-of-custody from synthesis through shipment. The full testing and verification workflow is documented below.

From Order to Delivery

Every GENEVIUM research peptide moves through a controlled six-stage workflow. The process begins at the moment a researcher places an order and ends with batch-labeled, cold-chain shipment. Each stage carries its own verification step, and every batch produced is tied to a publicly retrievable Certificate of Analysis.

The workflow below documents what happens at each stage and the analytical methods used to confirm purity, identity, and integrity before any compound leaves the facility.

1

Order Placed

Research customers complete checkout with age verification and a Research Use Only acknowledgment. Orders are reviewed for laboratory and research-context indicators before any batch is allocated. No compound ships without a confirmed RUO acknowledgment on file.

2

Synthesis

Peptides are produced via solid-phase peptide synthesis (SPPS) using Fmoc protection chemistry, the standard for research-grade peptide manufacturing. Coupling, deprotection, and cleavage are performed in controlled conditions with documented reagent lots and process parameters.

3

Purification

Crude peptide is purified by reverse-phase high-performance liquid chromatography (RP-HPLC). Target fractions are collected based on retention time and UV absorbance, then lyophilized to remove residual solvent and water before analytical testing.

4

Analytical Testing

Each batch is verified by two independent analytical methods. HPLC confirms purity at 99% or greater, and mass spectrometry (MS) confirms molecular weight against the theoretical mass of the target sequence. Batches that fail either threshold are rejected and not released for distribution.

5

COA Issued

A batch-specific Certificate of Analysis is generated for every lot. The COA documents HPLC purity, MS-confirmed molecular weight, batch number, and analysis date. Every COA is retrievable by batch number through the public COA lookup, with no login required.

6

Packaging and Shipping

Verified peptides are lyophilized into sealed glass vials, batch-labeled with lot and compound identifiers, and packaged with cold-chain materials appropriate to the compound stability profile. Orders ship with tracking and an order-specific batch reference.

Verifying a Batch

Every GENEVIUM order ships with a batch number printed on the vial label and included on the packing slip. Researchers can verify the analytical data for that specific lot at any time through the COA lookup, which returns the original Certificate of Analysis as a downloadable PDF.

Batch numbers are not regenerated and not reused. Each lot is permanently tied to its analytical record.

COA Lookup. Enter a batch number on the COA lookup page to retrieve the original Certificate of Analysis for any GENEVIUM research peptide.
Research Use Only. All GENEVIUM peptides are manufactured and tested for laboratory research applications. Every step of the workflow below is governed by analytical standards designed for non-clinical, in vitro use.
Updating
  • No products in the cart.